The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat
Open accessAbstract
human immunodeficiency virus, type 1 long terminal repeat RNA polymerase II TATA-binding protein Tat-associated kinase carboxyl-terminal domain Tat-associated histone acetyltransferase TBP-associated factor Human immunodeficiency virus, type 1 (HIV-1)1 is the etiological agent for the acquired immunodeficiency syndrome (AIDS). HIV-1 is a retrovirus that encodes a small nuclear transcriptional activator protein, Tat (Fig. 1). In vivo, Tat is required for virus replication and is conserved in the genomes of all primate lentiviruses (1Myers G. Korber B.T. Foley B.T. Jeang K-T. Mellors J.W. Wain-Hobson S. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM1996: III-11-III-26Google Scholar). Over the past decade, the transcriptional function(s) of Tat (reviewed in detail several years ago (2Jones K.A. Peterlin B.M. Annu. Rev. Biochem. 1994; 63: 717-743Crossref PubMed Scopus (559) Google Scholar)) has been intensely investigated. It has become clear that a primary role for Tat is in regulating productive and processive transcription from the HIV-1 long terminal repeat (LTR). Tat also has other activities; some are consistent with that of a secreted growth factor (3Chang H.K. Gallo R.C. Ensoli B.J. J. Biomed. Sci. 1995; 2: 189-202Crossref PubMed Scopus (91) Google Scholar, 4Trinh D.P. Brown K.M. Jeang K.T. Biochem. Biophys. Res. Commun. 1999; 256: 299-306Crossref PubMed Scopus (29) Google Scholar, 5Albini A. Ferrini S. Benelli R. Sforzini S. Giunciuglio D. Aluigi M.G. Proudfoot A.E. Alouani S. Wells T.N. Mariani G. Rabin R.L. Farber J.M. Noonan D.M. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13153-13158Crossref PubMed Scopus (245) Google Scholar) and a potentiator of reverse transcription (6Harrich D. Ulich C. Garcia-Martinez L.F. Gaynor R. EMBO J. 1997; 16: 1224-1235Crossref PubMed Scopus (124) Google Scholar). Here we review recent insights into the multifaceted activities of Tat. Tat is a transcriptional activator that binds to a short nascent stem-bulge-loop leader RNA, TAR (trans-activation responsive (7Berkhout B. Silverman R.H. Jeang K.T. Cell. 1989; 59: 273-282Abstract Full Text PDF PubMed Scopus (513) Google Scholar, 8Dingwall C. Ernberg I. Gait M.J. Green S.M. Heaphy S. Karn J. Lowe A.D. Singh M. Skinner M.A. EMBO J. 1990; 9: 4145-4153Crossref PubMed Scopus (340) Google Scholar, 9Cordingley M.G. La Femina R.L. Callahan P.L. Condra J.H. Sardana V.V. Graham D.J. Nguyen T.M. Le Grow K. Gotlib L. Schlabach A.J. Colonno R.J. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 8985-8989Crossref PubMed Scopus (176) Google Scholar, 10Calnan B.J. Biancalana S. Hudson D. Frankel A.D. Genes Dev. 1991; 5: 201-210Crossref PubMed Scopus (292) Google Scholar)), for its activity. The 101-amino acid Tat protein, with residues 1–72 encoded by a first exon and residues 73–101 encoded by a second exon, can be arbitrarily considered as containing several “domains” (11Kuppuswamy M. Subramanian T. Srinivasan A. Chinnadurai G. Nucleic Acids Res. 1989; 17: 3551-3561Crossref PubMed Scopus (208) Google Scholar) (Fig. 1). Of interest, it should be noted that whereas an 86-amino acid form of Tat, which exists for a few laboratory-passaged virus strains (e.g. LAI, HXB2, pNL4–3) (Fig. 1), has been frequently used; this version represents a truncated and not naturally full-length protein. Indeed, a single nucleotide change in LAI, HXB2, and/or pNL4–3 at putative residue 87 unmasks in these respective genomes the conserved 101 amino acids (Fig. 1) of Tat that are found in most in vivo isolates of virus. This suggests that the premature termination codon that exists in laboratory isolates at position 87 conceivably arose artifactually during tissue culture passaging (12Neuveut C. Jeang K.T. J. Virol. 1996; 70: 5572-5581Crossref PubMed Google Scholar). Thus, that more than 90% of the more than 100 extant independently characterized HIV-1 Tat proteins maintain the 101 (and not the 86) amino acid configuration (1Myers G. Korber B.T. Foley B.T. Jeang K-T. Mellors J.W. Wain-Hobson S. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM1996: III-11-III-26Google Scholar) is consistent with this interpretation. Hence, although residues 87–101 of Tat might not contribute greatly to the ex vivo propagation of HIV-1, their conservation in viruses that replicate in vivoprovides a good indication of their biological importance. In this regard, the second coding exon of Tat, which in many studies has been frequently not considered, has been shown to be significant in several biological assays (13Viglianti G. Mullins J.I. J. Virol. 1988; 62: 4523-4532Crossref PubMed Google Scholar, 14Tong-Starksen S. Baur A. Lu X.B. Peck E. Peterlin B.M. Virology. 1993; 195: 826-830Crossref PubMed Scopus (23) Google
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,249
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Zhu, Y., Pe’ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 696
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
Meyerhans, A., Cheynier, R., Albert, J., Seth, M., Kwok, S., Sninsky, J., Morfeldt-Månson, L., Asjö, B., & Wain-Hobson, S. (1989) · Cell · doi:10.1016/0092-8674(89)90942-2 · Cited by 651
Tat trans-activates the human immunodeficiency virus through a nascent RNA target
Berkhout, B., Silverman, R. H., & Jeang, K.-T. (1989) · Cell · doi:10.1016/0092-8674(89)90289-4 · Cited by 647
Self-citationCONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTER
Jones, K. A., & Peterlin, B. M. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003441 · Cited by 618
Induction of Apoptosis in Uninfected Lymphocytes by HIV-1 Tat Protein
Li, C. J., Friedman, D. J., Wang, C., Metelev, V., & Pardee, A. B. (1995) · Science · doi:10.1126/science.7716549 · Cited by 580
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
Mancebo, H. S. Y., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 544
Identification of multiple cyclin subunits of human P-TEFb
Peng, J., Zhu, Y., Milton, J. T., & Price, D. H. (1998) · Genes & Development · doi:10.1101/gad.12.5.755 · Cited by 519
Verdin, E., Paras, P., & Van Lint, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 510
Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II
Dahmus, M. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19009 · Cited by 498
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., Skinner, M. A., & Valerio, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6925 · Cited by 476
Structural and functional characterization of human immunodeficiency virus tat protein
Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., & Rosen, C. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.1-8.1989 · Cited by 429
COMMON THEMES IN ASSEMBLY AND FUNCTION OF EUKARYOTIC TRANSCRIPTION COMPLEXES
Zawel, L., & Reinberg, D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002533 · Cited by 427
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
Roy, S., Delling, U., Chen, C. H., Rosen, C. A., & Sonenberg, N. (1990) · Genes & Development · doi:10.1101/gad.4.8.1365 · Cited by 410
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., & Skinner, M. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07637.x · Cited by 407
Westendorp, M. O., Shatrov, V. A., Schulze-Osthoff, K., Frank, R., Kraft, M., Los, M., Krammer, P. H., Dröge, W., & Lehmann, V. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07030.x · Cited by 382
Lab., N. (. S. L. A. N., Myers, G., USDOE, W., Foley, B., Korber, B., Mellors, J. W., Jeang, K., & Wain–Hobson, S. (1997) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/463607 · Cited by 336
Self-citationHerrmann, C. H., & Rice, A. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1612-1620.1995 · Cited by 333
Calnan, B. J., Biancalana, S., Hudson, D., & Frankel, A. D. (1991) · Genes & Development · doi:10.1101/gad.5.2.201 · Cited by 332
Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation
O'Brien, T., Hardin, S., Greenleaf, A., & Lis, J. T. (1994) · Nature · doi:10.1038/370075a0 · Cited by 324
RNA recognition by Tat-derived peptides: Interaction in the major groove?
Weeks, K. M., & Crothers, D. M. (1991) · Cell · doi:10.1016/0092-8674(81)90020-9 · Cited by 320
Control of formation of two distinct classes of RNA polymerase II elongation complexes.
Marshall, N. F., & Price, D. H. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2078 · Cited by 309
Marzio, G., Tyagi, M., Gutierrez, M. I., & Giacca, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13519 · Cited by 305
Activation of Integrated Provirus Requires Histone Acetyltransferase
Benkirane, M., Chun, R. F., Xiao, H., Ogryzko, V. V., Howard, B. H., Nakatani, Y., & Jeang, K.-T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24898 · Cited by 296
Self-citationChurcher, M. J., Lamont, C., Hamy, F., Dingwall, C., Green, S. M., Lowe, A. D., Butler, P. J. G., Gait, M. J., & Karn, J. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1128 · Cited by 281
HIV-1 Tat protein mimicry of chemokines
Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Aluigi, M. G., Proudfoot, A. E. I., Alouani, S., Wells, T. N. C., Mariani, G., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13153 · Cited by 279
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein
Hauber, J., Malim, M. H., & Cullen, B. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1181-1187.1989 · Cited by 277
HIV-1 Tat protein trans-activates transcription in vitro
Marciniak, R. A., Calnan, B. J., Frankel, A. D., & Sharp, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90145-5 · Cited by 270
Parada, C. A., & Roeder, R. G. (1996) · Nature · doi:10.1038/384375a0 · Cited by 261
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis
Kuppuswamy, M., Subramanian, T., Srinivasan, A., & Chinnadurai, G. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.9.3551 · Cited by 255
Berkhout, B., & Jeang, K. T. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.139-149.1992 · Cited by 254
Self-citationDirect interaction of human TFIID with the HIV-1 transactivator Tat
Kashanchi, F., Piras, G., Radonovich, M. F., Duvall, J. F., Fattaey, A., Chiang, C.-M., Roeder, R. G., & Brady, J. N. (1994) · Nature · doi:10.1038/367295a0 · Cited by 245
A cDNA for a Protein That Interacts with the Human Immunodeficiency Virus Tat Transactivator
Nelbock, P., Dillon, P. J., Perkins, A., & Rosen, C. A. (1990) · Science · doi:10.1126/science.2194290 · Cited by 235
Repression of MHC Class I Gene Promoter Activity by Two-Exon Tat of HIV
Howcroft, T. K., Strebel, K., Martin, M. A., & Singer, D. S. (1993) · Science · doi:10.1126/science.8493575 · Cited by 223
Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
Vocero-Akbani, A. M., Heyden, N. V., Lissy, N. A., Ratner, L., & Dowdy, S. F. (1999) · Nature Medicine · doi:10.1038/4710 · Cited by 220
Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., & Fan, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6224-6233.1993 · Cited by 217
Self-citationImmune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway
Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, J., Chirmule, N., McCloskey, T., Pahwa, S., & Verdin, E. (1997) · Science · doi:10.1126/science.275.5305.1481 · Cited by 211
Zhou, Q. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3681 · Cited by 205
Hottiger, M. O., & Nabel, G. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8252-8256.1998 · Cited by 199
Connecting a promoter-bound protein to TBP bypasses the need for a transcriptional activation domain
Chatterjee, S., & Struhl, K. (1995) · Nature · doi:10.1038/374820a0 · Cited by 192
HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
Kato, H., Sumimoto, H., Pognonec, P., Chen, C. H., Rosen, C. A., & Roeder, R. G. (1992) · Genes & Development · doi:10.1101/gad.6.4.655 · Cited by 189
Garcia, J. A., Harrich, D., Pearson, L., Mitsuyasu, R., & Gaynor, R. B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03181.x · Cited by 187
Tat is required for efficient HIV‐1 reverse transcription
Harrich, D., Ulich, C., García‐Martínez, L. F., & Gaynor, R. B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1224 · Cited by 175
Biochemical and Functional Interactions between HIV-1 Tat Protein and TAR RNA
Rana, T. M., & Jeang, K.-T. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1206 · Cited by 173
Self-citationYang, X., Gold, M. O., Tang, D. N., Lewis, D. E., Aguilar-Cordova, E., Rice, A. P., & Herrmann, C. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12331 · Cited by 171
Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat
Chun, R. F., Semmes, O. J., Neuveut, C., & Jeang, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2615-2629.1998 · Cited by 151
Self-citationHIV-1 Tat Directly Interacts with the Interferon-Induced, Double-Stranded RNA-Dependent Kinase, PKR
McMillan, N. A. J., Chun, R. F., Siderovski, D. P., GALABRU, J., Toone, W. M., Samuel, C. E., Mak, T. W., Hovanessian, A. G., Jeang, K.-T., & Williams, B. R. G. (1995) · Virology · doi:10.1006/viro.1995.0014 · Cited by 147
Self-citationTat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat
Zhou, Q., & Sharp, P. A. (1996) · Science · doi:10.1126/science.274.5287.605 · Cited by 143
Weissman, J. D., Brown, J. A., Howcroft, T. K., Hwang, J. R., Chawla, A., Roche, P. A., Schiltz, L., Nakatani, Y., & Singer, D. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11601 · Cited by 137
The Human Immunodeficiency Virus Transactivator Tat Interacts with the RNA Polymerase II Holoenzyme
Cujec, T. P., Cho, H., Maldonado, E., Meyer, J., Reinberg, D., & Peterlin, B. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1817 · Cited by 114
Xiao, H., Friesen, J. D., & Lis, J. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5757 · Cited by 110
Self-citationChun, R. F., & Jeang, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27888 · Cited by 106
Self-citationRice, A. P., & Carlotti, F. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1864-1868.1990 · Cited by 99
Suñé, C., Hayashi, T., Liu, Y., Lane, W. S., Young, R. A., & García-Blanco, M. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.6029 · Cited by 99
Chang, H.-K., Gallo, R. C., & Ensoli, B. (1995) · Journal of Biomedical Science · doi:10.1159/000456857 · Cited by 94
Huang, L., Joshi, A., Willey, R. L., Orenstein, J. M., & Jeang, K.-T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06583.x · Cited by 93
Self-citationOkamoto, H., Sheline, C. T., Corden, J. L., Jones, K. A., & Peterlin, B. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11575 · Cited by 91
Sadaie, M. R., Rappaport, J., Benter, T., Josephs, S. F., Willis, R., & Wong‐Staal, F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9224 · Cited by 91
Tat-associated Kinase (P-TEFb): a Component of Transcription Preinitiation and Elongation Complexes
Ping, Y., & Rana, T. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7399 · Cited by 90
Carroll, R. G., Martarano, L., & Derse, D. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3460-3467.1991 · Cited by 87
Keen, N., Gait, M. J., & Karn, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2505 · Cited by 84
Effects of integration and replication on transcription of the HIV-1 long terminal repeat.
Jeang, K. T., Berkhout, B., & Dropulić, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74555-4 · Cited by 77
Self-citationViglianti, G. A., & Mullins, J. I. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4523-4532.1988 · Cited by 77
A cofactor, TIP30, specifically enhances HIV-1 Tatactivated transcription
Xiao, H., Tao, Y., Greenblatt, J., & Roeder, R. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2146 · Cited by 76
Self-citationNeuveut, C., & Jeang, K. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5572-5581.1996 · Cited by 69
Self-citationWu-Baer, F., Sigman, D. S., & Gaynor, R. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7153 · Cited by 64
The HIV-1 Tat cellular coactivator Tat–SF1 is a general transcription elongation factorPreprint
Li, X., & Green, M. R. (1998) · Genes & Development · doi:10.1101/gad.12.19.2992 · Cited by 64
Xiao, H., Neuveut, C., Benkirane, M., & Jeang, K.-T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8274 · Cited by 63
Self-citationKeen, N. J., Churcher, M. J., & Karn, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5260 · Cited by 59
Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins
Rice, A. P., & Carlotti, F. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.6018-6026.1990 · Cited by 53
Ulich, C., Dunne, A., Parry, E., Hooker, C. W., Gaynor, R. B., & Harrich, D. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2499-2508.1999 · Cited by 53
Promoter Activity of Tat at Steps Subsequent to TATA-Binding Protein Recruitment
Xiao, H., Lis, J. T., & Jeang, K.-T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.6898 · Cited by 52
Self-citationAssociation of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes
García-Martínez, L. F., Ivanov, D., & Gaynor, R. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6951 · Cited by 51
Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein
Marshall, N. F., Dahmus, G. K., & Dahmus, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31726 · Cited by 48
Verhoef, K., BAUER, M., Meyerhans, A., et al. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.1553 · Cited by 45
Chen, D., & Zhou, Q. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2863 · Cited by 43
Jeang, K.-T., & Berkhout, B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37126-1 · Cited by 42
Self-citationYean, D., & Gralla, J. D. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.3.831 · Cited by 37
Chang, Y., & Jeang, K. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.20.5465 · Cited by 35
Self-citationA Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus
Verhoef, K., & Berkhout, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2781-2789.1999 · Cited by 30
Epithelin/Granulin Growth Factors: Extracellular Cofactors for HIV-1 and HIV-2 Tat Proteins
Trinh, D. P., Brown, K. M., & Jeang, K.-T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0317 · Cited by 29
Self-citationSiderovski, D. P., Matsuyama, T., Frigerio, E., Chui, S., Min, X., Erfle, H. L., Sumner-Smith, M., Bamett, R. W., & Mak, T. W. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.20.5311 · Cited by 14
Liu, Y., Suñé, C., & García-Blanco, M. A. (1999) · Virology · doi:10.1006/viro.1998.9585 · Cited by 12
Blair, E. D., Roberts, C. M., & Clark‐Lewis, I. (1995) · Journal of Biomedical Science · doi:10.1159/000456822 · Cited by 12
Cited by
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Bromodomain: an acetyl‐lysine binding domain
Zeng, L., & Zhou, M.-M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03309-9 · Cited by 746
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 670
Arginine‐rich cell‐penetrating peptides
Schmidt, N., Mishra, A., Lai, G. H., & Wong, G. C. L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.046 · Cited by 521
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
Metadata
- Authors
- Jeang, K.-T., Xiao, H., & Rich, E. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-10
- Volume
- 274
- Issue
- 41
- Pages
- 28837-28840
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971592398
- Cited by
- 414
- References
- 84
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.